Chronic Kidney Disease Trial, Recruiting NCT06932042 Sponsor: Lebanese American University Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06932042
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been diagnosed with moderate to severe chronic kidney disease (stages 3–5), with kidney function measurements that have been stable for at least three months
  • People whose blood sugar and blood pressure levels are being managed and kept within a controlled range with treatment
  • People whose nutritional status has been assessed as normal using a standard nutritional screening tool called the GLIM criteria
  • People who are willing to attend an initial screening appointment and monthly in-person visits at the outpatient clinic at LAUMC-RH

Who may not be able to join:

  • People who have had an active infection, ongoing loss of appetite, vomiting, or diarrhea within the past month
  • People who have a serious illness that causes the body to break down, such as cancer, tuberculosis, liver failure, or heart failure
  • People who have had high potassium levels in their blood (above 5.5 mEq/L) at any point in the past six months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +9611786456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lebanese American University
Registry
ClinicalTrials.gov
Start date
28 May 2024
Est. completion
30 June 2026

Where this trial is recruiting

🇱🇧 Lebanon

Primary endpoints

Metabolic acidosis assessed by PTCO2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov